1. bookVolume 43 (2009): Issue 2 (June 2009)
Journal Details
First Published
30 Apr 2007
Publication timeframe
4 times per year
Open Access

Cancer cachexia-anorexia syndrome and skeletal muscle wasting

Published Online: 02 Apr 2009
Volume & Issue: Volume 43 (2009) - Issue 2 (June 2009)
Page range: 65 - 75
Journal Details
First Published
30 Apr 2007
Publication timeframe
4 times per year

Tisdale MJ. Pathogenesis of Cancer Cachexia. J Support Oncol 2003; 1: 159-68.Search in Google Scholar

Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer 1974; 33: 568-73.10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2Search in Google Scholar

DeWys WD. Anorexia as a general effect of cancer. Cancer 1972; 45: 2013-19.Search in Google Scholar

Perboni S, Inui A. Anorexia in cancer: role of feedeing-regulatory peptides. Phil Trans R Soc B 2006; 361: 1281-89.10.1098/rstb.2006.1863Search in Google Scholar

Geels P, Eisenhauer E, Bezjak A, Zee B, Day A. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metas tatic breast cancer. J Clin Oncol 2000; 18: 2395-405.10.1200/JCO.2000.18.12.2395Search in Google Scholar

Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997; 89: 1763-73.10.1093/jnci/89.23.1763Search in Google Scholar

Dahele M, Fearon KC. Research methodology: cancer cachexia syndrome. Palliative Medicine 2004; 18: 409-17.10.1191/0269216304pm906raSearch in Google Scholar

Bossola M, Muscaritoli M, Costelli P, Bellantone R, Pacelli F, Busquets S, et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1 518-23.10.1152/ajpregu.2001.280.5.R1518Search in Google Scholar

Rossi Fanelli F, Cangiano C, Ceci F, Cellerino R, Franchi F, Menichetti ET, et al. Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol 1986; 22: 89-95.10.1016/0277-5379(86)90346-9Search in Google Scholar

Padilla GV. Psychological aspects of nutrition and cancer. Surg Clin North Am 1986; 66: 1121-35.10.1016/S0039-6109(16)44078-8Search in Google Scholar

Knoll J. Endogenous anorectic agents-satietins. Annu Rev Pharmacol Toxicol 1988; 28: 247-68.10.1146/annurev.pa.28.040188.001335Search in Google Scholar

Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav 1991; 5: 185-215.10.1016/S0149-7634(05)80001-6Search in Google Scholar

Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999; 59: 4493-501.Search in Google Scholar

Inui A. Cancer Anorexia-Cachexia Syndrome: current issues in research and management. CA Cancer J Clin 2000; 52: 72-91.10.3322/canjclin.52.2.72Search in Google Scholar

Bosaeus I, Daneryd P, Lundholm K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 2002; 132 (suppl): S 3465-S 3466.10.1093/jn/132.11.3465SSearch in Google Scholar

Cohn SH, Gartenhaus W, Sawitsky A, Zanzi I, Vaswani A, Ellis KJ. Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism 1981; 30: 222-9.10.1016/0026-0495(81)90145-1Search in Google Scholar

Knox CS, Crosby CO, Fuerer ID, Buzby GP, Cliffor MD, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983; 197: 152-62.10.1097/00000658-198302000-00006Search in Google Scholar

Nixon DW, Kutner M, Heymsfield S, Foltz AT, Carty C, Seitz S, et al. Resting energy expenditure in lung and colon cancer. Metabolism 1988; 37: 1059-64.10.1016/0026-0495(88)90068-6Search in Google Scholar

Fredrix, EW, Soeters PB, Wouters EF, Deerenberg IM, Von-Meyerfeldt MF, Saris WH. Effect of different tumor types on resting energy expenditure. Cancer Res 1991; 51: 6138-41.Search in Google Scholar

Fredix EW, Saris WH, Soeters PB, Wouters EF, Kester AD, von Meyenfeldt MF, et al. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr 1990; 44: 749-52.Search in Google Scholar

Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325-31.10.1097/00000658-199404000-00001Search in Google Scholar

Moley JF, Aamodt R, Rumble W, Kaye W, Norton JA. Body cell mass in cancer bearing and anorexia patients. J Parenter Enteral Nutr 1987; 11: 219-22.10.1177/0148607187011003219Search in Google Scholar

Ohnuma T. Anorexia and cachexia. In: Kufe, Morton, Weichselbaum, editors. Cancer Medicine. Baltimore, MD: Williams & Wilkins; 1997. p. 3091-110.Search in Google Scholar

Pedersen BK. Exercise immunology. New York: Chapman & Hall; 1997.Search in Google Scholar

Adams GR, Haddad F. The relationship among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 1996; 81: 2509-16.10.1152/jappl.1996.81.6.2509Search in Google Scholar

Richardson RA, Davidson HI. Nutritional demands in acute and chronic illness. Proc Nutr Soc 2003; 62: 777-81.10.1079/PNS2003302Search in Google Scholar

Van Miert AS, Kaya F, Van Duin CT. Changes in food intake and forestomach motility of dwarf goats by recombinant bovine cytokines IL-1beta, IL-2 and IFN-gamma. Physiol Behav 1992; 52: 859-64.10.1016/0031-9384(92)90362-6Search in Google Scholar

Montuschi P, Tringali G, Curro D, Ciabattoni G, Parente L, Preziosi P, et al. Evidence that IL-1beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygense pathway. Eur J Pharmacol 1994; 252: 253-60.10.1016/0014-2999(94)90170-8Search in Google Scholar

Suto G, Kiraly A, Plourde V, Tache Y. Intravenous IL-1beta induced inhibition of gastric emptying: involvement of central corticotrophin-releasing factor and prostaglandin pathways in rats. Digest 1996; 57: 135-40.10.1159/000201326Search in Google Scholar

Suto G, Kiraly A, Tache Y. IL-1b inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterol 1994; 106: 1568-75.10.1016/0016-5085(94)90412-XSearch in Google Scholar

Sonti G, Ilyin SE, Plata-Salaman CR. Neuropeptide Y blocks and reverses IL-1b induced anorexia in rats. Peptides 1996; 17: 517-20.10.1016/0196-9781(96)00016-2Search in Google Scholar

Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic- pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998; 129: 229-40.10.7326/0003-4819-129-3-199808010-00012Search in Google Scholar

Shimon I, Yan X, Ray DW, Melmed S. Cytokine dependent gp 130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 1997; 100: 357-63.10.1172/JCI119541Search in Google Scholar

Argiles JM, Costelli P, Carbo N, Pallares-Trujillo J, Lopez-Soriano FJ. Tumor growth and nitrogen metabolism in the host. Int J Oncol 1999; 14: 479-86.Search in Google Scholar

Moldawer LL, Andersson C, Gelin J, Lundholm KG. Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 1988; 254: G 450-6.10.1152/ajpgi.1988.254.3.G450Search in Google Scholar

Laviano A, Meguid MM, Yang ZJ, Gleason JR, Cangiano C, Rossi Fanelli F. Cracking the riddle of cancer anorexia. Nutrit 1996; 12: 706-10.10.1016/S0899-9007(96)00164-5Search in Google Scholar

Laviano A, Gleason JR, Meguid MM, Yang ZJ, Cangiano C, Rossi Fanelli F. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Investig Med 2000; 48: 40-8.Search in Google Scholar

Otterness IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO. The effects of continuous administration of murine interleukin-1alpha in the rat. Physiol Behav 1988; 43: 797-804.10.1016/0031-9384(88)90379-4Search in Google Scholar

Mrosovsky N, Molony LA, Conn CA, Kluger MJ. Anorexic effects of interleukin in the rat. Am J Physiol 1989; 257: R 1315-21.10.1152/ajpregu.1989.257.6.R13152603994Search in Google Scholar

Yasumoto K, Mukaida N, Harada A, Kuno K, Akiyama M, Nakashima E. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma -bearing mice. Cancer Res 1995; 55: 921-7.Search in Google Scholar

Bodnar RJ, Pasternak GW, Sha P, Stock MJ. Medication of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Res 1989; 49: 6280-84.Search in Google Scholar

Kawakami M, Cerami A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981; 154: 631-7.10.1084/jem.154.3.631Search in Google Scholar

Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vitro. J Clin Invest 1987; 80: 184-90.10.1172/JCI113046Search in Google Scholar

Pape ME, Kim KH. Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and pre-adipocyte differentiation. Mol Endocrinol 1988; 2: 395-403.10.1210/mend-2-5-395Search in Google Scholar

Semb H, Peterson J, Tavernier J, Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987; 262: 8390-4.10.1016/S0021-9258(18)47576-XSearch in Google Scholar

Strassmann G, Fong M, Kenny JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681-4.10.1172/JCI115767Search in Google Scholar

Argiles JM, Garcia-Martinez C, Liovera M, Lopez-Soriano FJ. The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev 1992; 12: 637-52.10.1002/med.2610120605Search in Google Scholar

Prelovsek O, Mars T, Jevsek M, Podbregar M, Grubic Z. High dexamethasone concentration prevents stimulatory effects of TNF-alpha and LPS on IL-6 secretion from the precursors of human muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 2006; 291(6): 1651-6.10.1152/ajpregu.00020.2006Search in Google Scholar

Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2000; 283(6): 1272-8.10.1152/ajpendo.00255.2002Search in Google Scholar

Llovera M, Lopez-Soriano FJ, Argiles JM. Effects of tumor necrosis factor- on muscle protein turnover in female Wistars rats. J Natl Cancer Inst 1993; 85: 1334-9.10.1093/jnci/85.16.1334Search in Google Scholar

Darling G, Fraker DL, Jensen JC, Gorschboth CM, Norton JA. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res 1990; 50: 4008-13.Search in Google Scholar

Argiles JM, Alvarez B, Lopez - Sorriano FJ. The metabolic basis of cancer cachexia. Med Res Rev 1997; 17: 477-98.10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-RSearch in Google Scholar

Bianchi A, Bruce J, Cooper AL, Childs C, Kohli M, Morris ID, et al. Increased brown adipose tissue activity in children with malignant disease. Horm Metab Res 1989; 21: 640-1.10.1055/s-2007-1009308Search in Google Scholar

Strassmann G, Jacob CO, Evans R. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6 mediated cancer cachexia. J Immunol 1992; 148: 3674-8.10.4049/jimmunol.148.11.3674Search in Google Scholar

Tsujinaka T, Fujita J, Ebisui C. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996; 97: 244-9.10.1172/JCI118398Search in Google Scholar

Tamura S, Fujimoto-Ouchi K, Mori K, Endo M, Matsumoto T, Eden H, et al. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine carcinoma xenograft. Clin Cancer Res 1995; 1: 1353-8.Search in Google Scholar

Fearon KC, McMillan DC, Preston T, Winstanley P, Cruickshank AM, Shenkin A. Elevated circulating interleukin-6 is associated with an acute phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991; 213: 26-31.10.1097/00000658-199101000-00005Search in Google Scholar

Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994; 205: 182-5.10.3181/00379727-205-43695Search in Google Scholar

Pedersen BK, Febbraio MA. Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6. Physiol Rev 2007; 88: 1379-1406.Search in Google Scholar

Matthys P, Heremans H, Opdenakker G, Billiau A. Anti-interferon-gamma antibody treatment growth of Lewis lung tumors in mice and tumor-associated cachexia. Eur J Cancer. 1991; 27: 182-7.10.1016/0277-5379(91)90483-TSearch in Google Scholar

Langstain HN, Doherty GM, Fraker DL, Buresh C, Norton JA. The roles of -interferon and tumor necrosis factor in an experimental rat model of cancer cachexia. Cancer Res 1991; 51: 2302-6.Search in Google Scholar

Mori M, Yamaguchi K, Honda S, Nagasaki K, Ueda M, Abe O, et al. Cancer Cachexia Syndrome Developed in Nude Mice Bearing Melanoma Cells Producing Leukemia-inhibitory Factor. Cancer Res 1991; 51: 6656-9.Search in Google Scholar

Lorite MJ, Cariuk P, Tisdale MJ. Induction of muscle protein degradation by a tumor factor. Br J Cancer 1997; 76: 1035-40.10.1038/bjc.1997.504Search in Google Scholar

Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 1996; 56: 1256-61.Search in Google Scholar

Hussey HJ, Todorov PT, Field WN, Inagaki N, Tanaka Y, Ishitsuka H, et al. Effect of a fluorinated pyrimidine on cachexia and tumor growth in murine cachexia models: relationship with a proteolysis inducing factor. Br J Cancer 2000; 83: 56-62.10.1054/bjoc.2000.1278Search in Google Scholar

Cohn SH, Gartenhaus W, Sawitsky A, Rai K, Zani I, Vaswani A, et al. Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, andwater. Metabolism 1981; 30: 222-9.10.1016/0026-0495(81)90145-1Search in Google Scholar

Argiles JM, Moore-Carrasco R, Fuster G, Busquets S, Lopez Soriano FJ. Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol 2003; 35: 405-9.10.1016/S1357-2725(02)00251-0Search in Google Scholar

Mitch WE, Goldberg AL. Mechanisms of skeletal muscle wasting: The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335: 1897-1905.10.1056/NEJM1996121933525078948566Search in Google Scholar

Guttridge DC, Mayo MW, Madrid LV, Wang C, Baldwin AS. NF- B-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 298: 2363-7.10.1126/science.289.5488.236311009425Search in Google Scholar

Tisdale MJ. Biomedicine: protein loss in cancer cachexia. Science 2000; 289: 2293-4.10.1126/science.289.5488.229311041796Search in Google Scholar

Spina RJ, Chi MMY, Hopkins MG, Nemeth PM, Lowry OH, Holloszy JO. Mitochondrial enzymes increase in muscle in response to 7-10 days of cycle exercise. J Appl Physiol 1996; 80: 2250-4.10.1152/jappl.1996.80.6.22508806937Search in Google Scholar

Al-Majid S, McCarthy DO. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2001; 2: 186-97.10.1177/10998004010020030411547540Search in Google Scholar

Diffee GM, Kalfas K, Al-Majid S, McCarthy DO. Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol Cell Physiol 2002; 283: C 1376-82.10.1152/ajpcell.00154.200212372798Search in Google Scholar

Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002; 2: 862-71.10.1038/nrc92712415256Search in Google Scholar

Jurdana M. Radiation effects on skeletal muscle. Radiol Oncol 2008; 42: 15-22.10.2478/v10019-007-0034-5Search in Google Scholar

Recommended articles from Trend MD